San Bruno, CA, United States of America

Helene Gazzano-Santoro


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1994-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helene Gazzano-Santoro: Innovator in Biologics

Introduction

Helene Gazzano-Santoro is a prominent inventor based in San Bruno, California. She has made significant contributions to the field of biologics, particularly in the development of novel therapeutic methods. With a total of 2 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Her latest patents include innovative advancements in lipopolysaccharide binding protein derivatives. These derivatives are characterized by their ability to bind to and neutralize lipopolysaccharides (LPS) while lacking the immunostimulatory properties associated with holo-LBP. Additionally, she has developed therapeutic methods utilizing bactericidal/permeability increasing protein products. These methods aim to treat conditions such as the neutralization of heparin's anti-coagulant activity, inhibition of angiogenesis, and treatment of chronic inflammatory diseases.

Career Highlights

Helene is currently associated with Xoma Corporation, where she continues to push the boundaries of research and innovation. Her work is instrumental in advancing therapeutic options for patients suffering from various ailments.

Collaborations

Throughout her career, Helene has collaborated with notable professionals, including Roger G Little, II and James B Parent. These partnerships have fostered a collaborative environment that enhances the development of her innovative ideas.

Conclusion

Helene Gazzano-Santoro is a trailblazer in the field of biologics, with her patents reflecting her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches that could benefit many patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…